Delivery Order SPE2DB22D2006-SPE2DB25FW3DW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,666.72 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets (56-count packages). This firm fixed-price, non-set-aside contract was awarded on June 4, 2025, with an ultimate completion date of June 5, 2025. The pharmaceutical products will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. Varenicline is a prescription medication commonly used to support smoking...
- The Defense Logistics Agency awarded a $2,084.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varenicline 1 mg tablets (56-count units) with a contract ceiling value of $4,096.42. This is a firm fixed-price delivery order with no set-aside designation, completed competitively, and is scheduled for ultimate completion by September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) valued at $1,637.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child contract under the vendor's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varenicline 1mg tablets (56-count packages) valued at $7,668.62, with completion scheduled for July 30, 2025. This competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. The award was issued under a non-set-aside competitive process, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Varenicline 0.5 mg tablets (56-count packaging) with a ceiling value of $4,926.93. This competitively awarded contract utilizes firm fixed pricing and is not designated as a set-aside contract. The order is scheduled for ultimate completion on August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) with a ceiling value of $3,388.33. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varenicline 0.5 mg tablets (56-count units) under a firm fixed-price contract with a ceiling value of $5,061.75. The award, issued on May 22, 2025, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 23, 2025. This order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $7,432.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3DWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,189.62 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets (56-count) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Varenicline is a prescription medication used to support smoking cessation efforts and represents part of the broader pharmaceutical supply requirements for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies comprehensive medical commodities including medications, vaccines, and specialized healthcare products to support military healthcare programs globally. The company's extensive federal contract portfolio and demonstrated capability to fulfill diverse pharmaceutical requirements through open competition have established it as a critical vendor within the federal medical supply chain serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/6/25 |